Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Comment by Leafs4Lifeon Apr 26, 2018 7:07pm
112 Views
Post# 27947494

RE:RE:RE:Financials

RE:RE:RE:Financials You don't seem to be very good at reading comprehension so I will try to explain my points in simpler terms. Investors are not interested in LDS because of what they will read in financials. The market doesn't care about what happened in 2017. 2017 is already priced into the stock.

The market wants to see LDS products on shelves across california. When Reveur and Cannastrips are available in dispensaries for sale the stock will respond. Once the company is selling products then their financials will become important. If you think that statement is "WRONG" then you're going to have to explain why.

Or maybe you're just an angry person. It doesn't seem like you actually care to exchange information or participate in a debate, you just want to scream on a message board. I understand, it makes you feel better to shout on the internet. Go have a beer on a patio somewhere, sunshine and booze is better than internet trolling. 

DustDevil667 wrote: Absolutely dude. Also , everything you just said is completely wrong. Breaking ground on their facility .... WRONG ! Fulfilling orders ...... WRONG !
Leafs4Life wrote: You honestly think 2017 financials are going to move this stock (up or down) in a significant way? Investors in LDS are here because of what will happen in the future when their products are on shelves across the state, and they've broken ground on their grow facility, and they are fulfilling orders for cannabis oil. Nobody who follows this name gives a damn how much consulting revenue they generated. And nobody who knows what they're looking at will be surprised they haven't made much money... they didn't ship a product.

I think you're out to lunch on this one, dude.  

DustDevil667 wrote: TGIF $5 million last 6 months. LDS will be lucky to accomplish 1/10th of that in their last 6 months. Pretty much guaranteed to see the .30s or less 

 




Bullboard Posts